Last reviewed · How we verify
QLM3004 Concentration 2
QLM3004 Concentration 2 is a drug that targets the molecular target to exert its therapeutic effect.
At a glance
| Generic name | QLM3004 Concentration 2 |
|---|---|
| Sponsor | Qilu Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action of QLM3004 Concentration 2 is not well understood, but it is believed to work by binding to the molecular target, which leads to a cascade of downstream effects that ultimately result in the therapeutic effect.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |